ESMO Plenary Jul 2022 - ESMO Virtual Plenaries: July 2022
Jul 14 - Jul 15, 2022 | LuganoSwitzerland
LARVOL is not affiliated with ESMO Virtual Plenaries: July 2022 and all trademarks, logos, and brand names are property of their respective owners
Condition
Product
MOA
Trial Name/ID
Showing 1 abstracts linked to Trials
Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up